LeonaBio Depreciation & Amortization Growth & History (LONA)
LeonaBio's depreciation and amortization was $972,000 for fiscal 2025.
View full LeonaBio company overviewLeonaBio annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $972,000 | $2,000 | +0.21% |
| 2024 | 2024-12-31 | $970,000 | $1,000 | +0.10% |
| 2023 | 2023-12-31 | $969,000 | $124,000 | +14.67% |
| 2022 | 2022-12-31 | $845,000 | $366,000 | +76.41% |
| 2021 | 2021-12-31 | $479,000 | $477,000 | +23850.00% |
| 2020 | 2020-12-31 | $2,000 | $0 | 0.00% |
| 2019 | 2019-12-31 | $2,000 | — | — |
LeonaBio quarterly depreciation and amortization
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $200,000 | $0 | 0.00% |
| Q1 2026 | 2026-03-31 | $231,000 | −$12,000 | −4.94% |
| Q4 2025 | 2025-12-31 | $243,000 | — | — |
| Q3 2025 | 2025-09-30 | $200,000 | $0 | 0.00% |
| Q2 2025 | 2025-06-30 | $200,000 | $0 | 0.00% |
| Q1 2025 | 2025-03-31 | $243,000 | $1,000 | +0.41% |
| Q3 2024 | 2024-09-30 | $200,000 | −$44,000 | −18.03% |
| Q2 2024 | 2024-06-30 | $200,000 | −$44,000 | −18.03% |
| Q1 2024 | 2024-03-31 | $242,000 | $6,000 | +2.54% |
| Q3 2023 | 2023-09-30 | $244,000 | $13,000 | +5.63% |
| Q2 2023 | 2023-06-30 | $244,000 | $23,000 | +10.41% |
| Q1 2023 | 2023-03-31 | $236,000 | $82,000 | +53.25% |
| Q3 2022 | 2022-09-30 | $231,000 | $108,000 | +87.80% |
| Q2 2022 | 2022-06-30 | $221,000 | $103,000 | +87.29% |
| Q1 2022 | 2022-03-31 | $154,000 | $42,000 | +37.50% |
| Q3 2021 | 2021-09-30 | $123,000 | $123,000 | — |
| Q2 2021 | 2021-06-30 | $118,000 | $118,000 | — |
| Q1 2021 | 2021-03-31 | $112,000 | $112,000 | — |
| Q3 2020 | 2020-09-30 | $0 | — | — |
| Q2 2020 | 2020-06-30 | $0 | — | — |
| Q1 2020 | 2020-03-31 | $0 | — | — |
LeonaBio depreciation and amortization trends
Over the last five fiscal years, LeonaBio's depreciation and amortization increased from $2,000 to $972,000, a change of $970,000. The latest reported quarter, Q2 2026, shows $200,000.
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review LeonaBio source filings ↗